Sign In

Colin Orford

Senior Vice President Drug Development Services at ICON plc

Colin Orford is a seasoned professional with over 26 years of experience in the Pharmaceutical Sector, having worked with renowned companies like SmithKline Beecham, Glaxo SmithKline, Novartis, Quintiles, Eisai, and ICON.

With 17 years of project team leadership and project management experience, Colin has led multi-disciplinary, global drug development teams across all phases of development, ensuring projects are delivered successfully within the agreed profile, timelines, and budget.

He boasts strong expertise in neurosciences, particularly in areas such as depression, anxiety, Alzheimer's, and sleep disorders, along with a broader experience that includes epilepsy, MS (RRMS and SPMS), and pain management.

Colin has excelled in alliance management by co-chairing two global programs and leading due diligence teams for assets in Phases I to III, showcasing his in-depth understanding of regulatory guidelines for the US, EU, and Japan.

His educational background includes a PhD in Microbial Biochemistry and a BSc in Biochemistry from the University of Westminster.

Currently, he holds the position of Senior Vice President Drug Development Services at ICON plc, having previously served as the Vice President of Product Development at the same organization.

Prior to his current role, Colin held key positions such as Global Head of Project Operations at Eisai, Senior Director of CNS project management at Quintiles, and various project leadership roles at GlaxoSmithKline and Novartis.

Before his corporate roles, Colin started his career as a Post-Doctoral Research Assistant at St Bartholomew's Hospital Medical School, Department of Biochemistry.

C
Add to my network

Location

Dartford, England, United Kingdom